Seq2scFv: a toolkit for the comprehensive analysis of display libraries from long-read sequencing platforms
Antibodies have emerged as the leading class of biotherapeutics, yet traditional screening methods face significant time and resource challenges in identifying lead candidates. Integrating high-throughput sequencing with computational approaches marks a pivotal advancement in antibody discovery, exp...
Saved in:
Main Authors: | Marianne Bachmann Salvy (Author), Luca Santuari (Author), Emanuel Schmid-Siegert (Author), Nikolaos Lykoskoufis (Author), Ioannis Xenarios (Author), Bulak Arpat (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AI-accelerated therapeutic antibody development: practical insights
by: Luca Santuari, et al.
Published: (2024) -
"Stapling" scFv for multispecific biotherapeutics of superior properties
by: Lauren E. Boucher, et al.
Published: (2023) -
Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments
by: Francesco Nannini, et al.
Published: (2021) -
Implementation of a Design of Experiments to Improve Periplasmic Yield of Functional ScFv Antibodies in a Phage Display Platform
by: Marjan Abri Aghdam, et al.
Published: (2022) -
The improvement of anti-HER2 scFv soluble expression in Escherichia coli
by: Farzaneh Farshdari, et al.
Published: (2020)